Missouri Bill Would Allow Clinical Trials on Psychedelic Therapy for Veterans, First Responders
Missouri's new bill enables psychedelic-assisted therapy clinical trials specifically for veterans and first responders. These clinical trials aim to generate rigorous safety and efficacy data. Psychedelic-assisted therapy clinical trials represent a…
Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Directions
This review critically examines dietary bioactives alzheimer s disease clinical trials, focusing on cannabinoids and other compounds. It provides clinicians with an evidence-based assessment to distinguish promising treatments from marketing claims.…
Quantum Biopharma Seeks FDA Clearance for Lucid-MS Phase 2 Trial
Quantum Biopharma is advancing a cannabis-based therapeutic phase 2 trial for Lucid-MS. This trial targets cognitive symptoms in multiple sclerosis patients. The phase 2 trial is a critical step to evaluate efficacy beyond safety.
Exploring Neuroprotective Cannabis Clinical Trials and Their Impact
Neuroprotective cannabis clinical trials are advancing research into treatments for neurological disorders. These trials explore cannabis compounds' potential to protect nerve cells. Understanding clinical evidence helps guide safe and effective use.
Experimental Cannabis Extract Shows Promise for Chronic Back Pain
An experimental cannabis extract chronic back pain trial has shown promising results in reducing symptoms. This research adds valuable clinical evidence for cannabis in pain management. Patients with chronic back pain may benefit from emerging cannabis…
Enrollees Sought for Trial of Vaccine for C. diff – UW Medicine | Newsroom
The C diff vaccine trial at UW Medicine is recruiting participants to evaluate a preventive vaccine against Clostridioides difficile infections. This vaccine trial aims to reduce the risk of severe colitis caused by C diff, especially in vulnerable…
Texas Launches State-Sponsored Psychedelic Research with Ibogaine Trials
Texas is pioneering state-sponsored psychedelic research by initiating ibogaine clinical trials for addiction treatment. This approach represents a significant shift in regulatory pathways at the state level. State-sponsored psychedelic research could…
Lawmakers Debate Regulation of Psychedelic Clinical Trials
Legislative frameworks are shaping the regulation of psychedelic clinical trials, impacting patient access to emerging therapies. As FDA approval processes progress for psilocybin and MDMA, lawmakers debate safety and training protocols. Psychedelic…
Bill Would Increase Funding for Pediatric Cancer Research in Iowa – YouTube
Pediatric cancer research funding is critical to advancing cannabis-based therapies for symptom management in young patients. This bill aims to increase support for such research in Iowa. Dedicated funding can help address unique pediatric considerations…
Cell Therapy Eases Parkinson’s Motor Symptoms in Early Trial
Cell therapy Parkinsons disease trials offer new hope for easing motor symptoms. Early-phase research suggests potential benefits in neurodegeneration treatment. Understanding these advances is crucial for clinicians and patients.